OP01.20: The effect of incorporating ultrasonographic risk assessment for Down syndrome (URAD), with maternal age and serum screening on rate of amniocentesis (original) (raw)

Prenatal Isolated Ventricular Septal Defect May Not Be Associated with Trisomy 21

Journal of Clinical Medicine, 2014

Prenatally detectable congenital heart defects in fetuses with Down syndrome

Ultrasound in Obstetrics & Gynecology, 2011

Shortening fraction of the right ventricle: a comparison between euploid and trisomy 21 fetuses at week 11 to week 13 and 6 days of gestation

Pavel Calda

Prenatal Diagnosis, 2011

View PDFchevron_right

Prenatal sonographic findings in 207 fetuses with trisomy 21

Csaba Pap

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2007

View PDFchevron_right

Analysis of Antenatal Sonographic Features of the Fetuses with Trisomy 21

Fusun Varol

Iranian Journal of Radiology

View PDFchevron_right

Cardiac function in trisomy 21 fetuses

S. Clur

Ultrasound in Obstetrics & Gynecology, 2011

View PDFchevron_right

Minor sonographic signs of trisomy 21 at 15–20 weeks' gestation in fetuses born without malformations: a prospective study

A. Sciarrone, E. Viora

2001

View PDFchevron_right

Correlation of Prenatal Sonographic Diagnosis and Morphologic Findings of Fetal Autopsy in Fetuses With Trisomy 21

Zoltán Papp

Journal of Ultrasound in Medicine, 2007

View PDFchevron_right

Left ventricle shortening fraction: a comparison between euploid and trisomy 21 fetuses in the first trimester

Pavel Calda

Prenatal Diagnosis, 2010

View PDFchevron_right

Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan

Stefano Faiola, G. Rembouskos

Ultrasound in Obstetrics and Gynecology, 2005

View PDFchevron_right

Relationship of isolated fetal intracardiac echogenic focus to trisomy 21 at the mid-trimester sonogram in women younger than 35 years

Nigel Anderson

Ultrasound in Obstetrics & Gynecology, 2003

View PDFchevron_right

Isolated echogenic foci in the fetal heart: do they increase the risk of trisomy 21 in a population previously screened by nuchal translucency?

Federico Prefumo

Ultrasound in Obstetrics and Gynecology, 2001

View PDFchevron_right

Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free β-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks

Kevin Spencer

Ultrasound in Obstetrics and Gynecology, 2006

View PDFchevron_right

The Association between Congenital Heart Disease and Down Syndrome in Prenatal Life

A. Tartaglione

Journal of Diagnostic Medical Sonography, 2000

View PDFchevron_right

P117Echocardiographic findings in fetuses with trisomy 18

K. Pohlodek

Ultrasound in Obstetrics and Gynecology, 2002

View PDFchevron_right

Mitral valve-tricuspid valve distance as a sonographic marker of trisomy 21

Christopher Glantz

Ultrasound in Obstetrics and Gynecology, 2010

View PDFchevron_right

Poor outcome in Down syndrome fetuses with cardiac anomalies or growth retardation

Frans Los

American Journal of Medical Genetics Part A, 2002

View PDFchevron_right

Association between isolated mild symmetrical ventriculomegaly and fetal chromosomal aberrations

Luka Joksimovic

Genetika, 2021

View PDFchevron_right

Detection Rate and Sonographic Signs of Trisomy 21 Fetuses at 14-17 Weeks of Gestation

Ido Solt

The Israel Medical Association journal : IMAJ, 2017

View PDFchevron_right

Outcome of Prenatally-Detected Fetal Ventriculomegaly

Nidhish Sharma, Pratima Dash, Pushpa Saviour

Journal of Fetal Medicine, 2015

View PDFchevron_right

Intrapartum fetal heart rate patterns of trisomy 21 fetuses: A case–control study

daniela chen

Early Human Development, 2016

View PDFchevron_right

Nuchal fold thickness, nasal bone absence or hypoplasia, ductus venosus reversed flow and tricuspid valve regurgitation in screening for trisomies 21, 18 and 13 in the early second trimester

Christoph Berg

Ultrasound in Obstetrics and Gynecology, 2010

View PDFchevron_right

Fetal Tricuspid Regurgitation at the 11 + 0 to 13 + 6-Week Scan: Association With Chromosomal Defects and Reproducibility of the Method

Stefano Faiola

Obstetrical & Gynecological Survey, 2006

View PDFchevron_right

Echogenic intracardiac focus: A sonographic sign for fetal down syndrome

Bryann Bromley

Obstetrics & Gynecology, 1995

View PDFchevron_right

Prenatal evaluation and postnatal early outcomes of fetal ventriculomegaly

Cagri Gulumser, Aylin Tarcan

European Journal of Paediatric Neurology, 2014

View PDFchevron_right

Mild cerebral ventriculomegaly in fetuses: characteristics and outcome

Israel Goldstein

Fetal diagnosis and therapy

View PDFchevron_right

Prenatal detection of trisomy 21 by second-trimester ultrasound examination and maternal age in a non-selected population of 49 314 births in Norway

K. Offerdal, Harm-gerd Blaas

Ultrasound in Obstetrics and Gynecology, 2008

View PDFchevron_right

Outcome of Fetuses Diagnosed With Atrioventricular Septal Defect

Marie-France Delisle

Obstetrics & Gynecology, 1999

View PDFchevron_right

Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks

Themistoklis Dagklis, N. Maiz

Ultrasound in Obstetrics & Gynecology, 2008

View PDFchevron_right

In utero progression of mild fetal ventriculomegaly

Barbara Parilla

International Journal of Gynecology & Obstetrics, 2006

View PDFchevron_right

Genetic sonography: the historical and clinical role of fetal echocardiography

Greggory DeVore

Ultrasound in Obstetrics and Gynecology, 2010

View PDFchevron_right

Trisomy 21

Naomi Greene

Clinics in Perinatology, 2001

View PDFchevron_right

Moderate associated fetal ventriculomegaly: prenatal diagnosis

Cristina-Crenguta Albu

International Journal of Research in Medical Sciences

View PDFchevron_right

OP01.20: The effect of incorporating ultrasonographic risk assessment for Down syndrome (URAD), with maternal age and serum screening on rate of amniocentesis (original) (raw)

Related papers